Uniqure N.V. (QURE)

$17.39 +0.23 (1.34%)
Market Cap 1.07B
Revenue (ttm) 16.10M
Net Income (ttm) -198.97M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,235.84%
Debt to Equity Ratio 0.25
Volume 1,040,300
Avg Vol 3,629,512
Day's Range N/A - N/A
Shares Out 62.53M
Stochastic %K 91%
Beta 0.75
Analysts Strong Sell
Price Target $38.00

Company Profile

uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial t...

Industry: Biotechnology
Sector: Healthcare
Phone: 31 20 240 6000
Address:
Paasheuvelweg 25, Amsterdam, Netherlands
Biorocksme
Biorocksme Apr. 2 at 12:25 AM
$QURE Apr 13 fda important
2 · Reply
EingeLTrade
EingeLTrade Mar. 31 at 5:58 PM
HOW ON EARTH YOU TRADE THIS??? $QURE
0 · Reply
Dkll303
Dkll303 Mar. 31 at 12:42 PM
$AGIO do you believe these losers ??? Misfits , are they the same as Matt Kapusta at $QURE …only to be told See ya …by the FDA Where is the document , specifically stating the results of the preFDA meeting, aligning the FDA with acceptance and expedited approval..HUH Where is the proof ..Reuters would print this !!!! Proof is necessary with these misfits
0 · Reply
Djjazzyjeff
Djjazzyjeff Mar. 30 at 5:06 PM
$QURE where is thinkingman with his ground breaking TA
0 · Reply
LUNR_Gateway_SpaceExIPO
LUNR_Gateway_SpaceExIPO Mar. 25 at 7:41 PM
$QURE 🤔 WAS I RIGHT Or WAS I REALLY REALLY REALLY RiGHT? And did you buy LUNR
0 · Reply
calidave123
calidave123 Mar. 25 at 4:40 PM
$QURE
0 · Reply
QuantInsider
QuantInsider Mar. 23 at 10:57 PM
What’s up with $QURE today? Just tiny April put and call sweeps totaling $23.7K on InsiderFinance No big moves or fresh news Looks like low conviction positioning after that 5-day bounce No clear edge here so it’s not smart money yet Keep an eye on price action or wait for bigger one-sided flow before making any moves
0 · Reply
stilluminati
stilluminati Mar. 23 at 4:16 PM
$QURE GlobeNewsWire: $QURE ROSEN, NATIONAL TRIAL LAWYERS, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Secur... Full analysis → https://www.stockilluminati.com/qure/news.php..
0 · Reply
anachartanalyst
anachartanalyst Mar. 23 at 3:01 PM
$QURE https://anachart.com/wp-content/uploads/ana_temp/1774278089_soc-img.jpg
0 · Reply
verusabiz
verusabiz Mar. 23 at 2:28 PM
$QURE trying to get back in at 15.60
0 · Reply
Latest News on QURE
UNIQURE DEADLINE APPROACHING: Bragar Eagel & Squire, P.C. Encourages uniQure N.V.

Apr 2, 2026, 5:51 PM EDT - 4 days ago

UNIQURE DEADLINE APPROACHING: Bragar Eagel & Squire, P.C. Encourages uniQure N.V.

QURE SHAREHOLDER NOTICE: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of "Distorted" Data

Mar 30, 2026, 3:52 PM EDT - 7 days ago

QURE SHAREHOLDER NOTICE: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of "Distorted" Data

This biotech's stock is soaring after a ‘polarizing' FDA official is stepping down

Mar 9, 2026, 9:18 AM EDT - 4 weeks ago

This biotech's stock is soaring after a ‘polarizing' FDA official is stepping down

Federal health officials attacked an Amsterdam-based biotech company seeking approval of a Huntington's disease treatment and accused it of lying

Mar 5, 2026, 6:01 PM EST - 4 weeks ago

Federal health officials attacked an Amsterdam-based biotech company seeking approval of a Huntington's disease treatment and accused it of lying

FDA official calls UniQure's gene therapy a 'failed' treatment for Huntington's disease

Mar 5, 2026, 2:42 PM EST - 4 weeks ago

FDA official calls UniQure's gene therapy a 'failed' treatment for Huntington's disease

Sr. FDA official calls Uniqure's Huntington's disease treatment a failure

Mar 5, 2026, 1:11 PM EST - 4 weeks ago

Sr. FDA official calls Uniqure's Huntington's disease treatment a failure

FDA Defends Call For Placebo Study In uniQure Huntington's Gene Therapy Trial

Mar 5, 2026, 12:11 PM EST - 4 weeks ago

FDA Defends Call For Placebo Study In uniQure Huntington's Gene Therapy Trial

FDA official says UniQure fell short on Huntington's trial, defends new study request

Mar 4, 2026, 11:01 PM EST - 4 weeks ago

FDA official says UniQure fell short on Huntington's trial, defends new study request

These Analysts Cut Their Forecasts On uniQure Following Q4 Results

Mar 3, 2026, 9:34 AM EST - 4 weeks ago

These Analysts Cut Their Forecasts On uniQure Following Q4 Results

FDA tells UniQure study data insufficient for brain disorder therapy application

Mar 2, 2026, 7:22 AM EST - 5 weeks ago

FDA tells UniQure study data insufficient for brain disorder therapy application

uniQure Announces 2025 Financial Results and Provides Recent Company Updates

Mar 2, 2026, 7:05 AM EST - 5 weeks ago

uniQure Announces 2025 Financial Results and Provides Recent Company Updates

QURE INVESTOR REMINDER: uniQure N.V. Investors Have Until April 13, 2026 To Seek Lead Plaintiff Role

Feb 25, 2026, 6:00 PM EST - 5 weeks ago

QURE INVESTOR REMINDER: uniQure N.V. Investors Have Until April 13, 2026 To Seek Lead Plaintiff Role

uniQure to Announce 2025 Financial Results

Feb 23, 2026, 7:05 AM EST - 6 weeks ago

uniQure to Announce 2025 Financial Results

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 13, 2026 in uniQure Lawsuit - QURE

Feb 19, 2026, 10:00 AM EST - 6 weeks ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 13, 2026 in uniQure Lawsuit - QURE

UniQure N.V. (QURE) Securities Fraud: Contact Berger Montague To Discuss Your Rights

Feb 18, 2026, 10:06 AM EST - 6 weeks ago

UniQure N.V. (QURE) Securities Fraud: Contact Berger Montague To Discuss Your Rights

UNIQURE N.V. (QURE) INVESTOR ALERT Investors With Large Losses in uniQure N.V.

Feb 17, 2026, 8:16 AM EST - 6 weeks ago

UNIQURE N.V. (QURE) INVESTOR ALERT Investors With Large Losses in uniQure N.V.

Early uniQure Fabry Trial Shows Lasting Enzyme Boost, Safety Watch

Feb 6, 2026, 1:58 PM EST - 2 months ago

Early uniQure Fabry Trial Shows Lasting Enzyme Boost, Safety Watch

uniQure Announces Updated Preliminary AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease

Feb 6, 2026, 7:05 AM EST - 2 months ago

uniQure Announces Updated Preliminary AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease

uniQure Announces Type A Meeting Scheduled with FDA

Jan 9, 2026, 7:05 AM EST - 3 months ago

uniQure Announces Type A Meeting Scheduled with FDA

What's Going On With uniQure Stock On Tuesday?

Dec 16, 2025, 12:17 PM EST - 3 months ago

What's Going On With uniQure Stock On Tuesday?

Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years

Dec 7, 2025, 12:01 PM EST - 4 months ago

Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years

Why uniQure Stock Is Trading Lower After FDA Meeting Update

Dec 4, 2025, 1:30 PM EST - 4 months ago

Why uniQure Stock Is Trading Lower After FDA Meeting Update

uniQure Provides Regulatory Update on AMT-130 for Huntington's Disease

Dec 4, 2025, 7:05 AM EST - 4 months ago

uniQure Provides Regulatory Update on AMT-130 for Huntington's Disease

uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - QURE

Nov 14, 2025, 4:17 AM EST - 5 months ago

uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - QURE

QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm

Nov 12, 2025, 10:00 AM EST - 5 months ago

QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm

uniQure Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Nov 10, 2025, 7:05 AM EST - 5 months ago

uniQure Announces Third Quarter 2025 Financial Results and Provides Corporate Update

uniQure to Announce Third Quarter 2025 Financial Results

Nov 6, 2025, 7:05 AM EST - 5 months ago

uniQure to Announce Third Quarter 2025 Financial Results

Biorocksme
Biorocksme Apr. 2 at 12:25 AM
$QURE Apr 13 fda important
2 · Reply
EingeLTrade
EingeLTrade Mar. 31 at 5:58 PM
HOW ON EARTH YOU TRADE THIS??? $QURE
0 · Reply
Dkll303
Dkll303 Mar. 31 at 12:42 PM
$AGIO do you believe these losers ??? Misfits , are they the same as Matt Kapusta at $QURE …only to be told See ya …by the FDA Where is the document , specifically stating the results of the preFDA meeting, aligning the FDA with acceptance and expedited approval..HUH Where is the proof ..Reuters would print this !!!! Proof is necessary with these misfits
0 · Reply
Djjazzyjeff
Djjazzyjeff Mar. 30 at 5:06 PM
$QURE where is thinkingman with his ground breaking TA
0 · Reply
LUNR_Gateway_SpaceExIPO
LUNR_Gateway_SpaceExIPO Mar. 25 at 7:41 PM
$QURE 🤔 WAS I RIGHT Or WAS I REALLY REALLY REALLY RiGHT? And did you buy LUNR
0 · Reply
calidave123
calidave123 Mar. 25 at 4:40 PM
$QURE
0 · Reply
QuantInsider
QuantInsider Mar. 23 at 10:57 PM
What’s up with $QURE today? Just tiny April put and call sweeps totaling $23.7K on InsiderFinance No big moves or fresh news Looks like low conviction positioning after that 5-day bounce No clear edge here so it’s not smart money yet Keep an eye on price action or wait for bigger one-sided flow before making any moves
0 · Reply
stilluminati
stilluminati Mar. 23 at 4:16 PM
$QURE GlobeNewsWire: $QURE ROSEN, NATIONAL TRIAL LAWYERS, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Secur... Full analysis → https://www.stockilluminati.com/qure/news.php..
0 · Reply
anachartanalyst
anachartanalyst Mar. 23 at 3:01 PM
$QURE https://anachart.com/wp-content/uploads/ana_temp/1774278089_soc-img.jpg
0 · Reply
verusabiz
verusabiz Mar. 23 at 2:28 PM
$QURE trying to get back in at 15.60
0 · Reply
calidave123
calidave123 Mar. 23 at 1:15 PM
$QURE
0 · Reply
Dkll303
Dkll303 Mar. 23 at 10:52 AM
$QURE $10 ..incoming ….followed by $3. MATT BOUGHT YUGE PUTS
0 · Reply
Dkll303
Dkll303 Mar. 23 at 10:49 AM
$QURE Where is @FundingMyBoat …the useless dweeb that holds QURE in high esteem. Aiding and abetting, MATT , in a trial that from the outset was flawed No placebo !!! …even Spanky at 5 years of age , knows better
0 · Reply
Dkll303
Dkll303 Mar. 23 at 10:47 AM
$QURE Go to Vegas ….MATT FCUKED THIS UP for the 5th time in 5 years .
0 · Reply
Dkll303
Dkll303 Mar. 23 at 10:46 AM
$QURE $DJT MATT ( your felon CEO) and TRUMP ( FELON ) have at least one thing in common They know how to destroy , lie and cheat You got the lie ( no placebo) Didn’t sell to CSL Behring in 2020 ( destroyed QURE) Plays the market with his ex cohorts in the brokerage business With your value !!! ( cheat ) Meet MATT and his Brother TRUMP.
0 · Reply
MF__DOOM
MF__DOOM Mar. 21 at 7:52 PM
$QQQ $QURE $SPY still holding
0 · Reply
Don_Frye
Don_Frye Mar. 20 at 8:05 PM
$QURE i need a few wins , and fast . yeezz
0 · Reply
topstockalerts
topstockalerts Mar. 20 at 5:26 PM
$QURE larger cap biotech feel, moves more controlled but can still trend when sentiment shifts.
0 · Reply
verusabiz
verusabiz Mar. 20 at 4:02 PM
$QURE Anyone know anything about why this is moving up? I only have 2,000 shares but looks good
1 · Reply
clarksonhockey
clarksonhockey Mar. 20 at 3:53 PM
$QURE did news leak? Buyout???? Come to daddy!
1 · Reply
MAGA1717
MAGA1717 Mar. 20 at 3:51 PM
$QURE oh yes BB… yippie!
0 · Reply
rooneyray
rooneyray Mar. 20 at 3:32 PM
$QURE Marty Makary buying up shares before he announces his departure from the FDA
1 · Reply